Chevy Chase Trust Holdings, Inc. Abb Vie Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q3 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 981,596 shares of ABBV stock, worth $167 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
981,596
Previous 997,199
1.56%
Holding current value
$167 Million
Previous $171 Million
13.33%
% of portfolio
0.6%
Previous 0.55%
Shares
30 transactions
Others Institutions Holding ABBV
# of Institutions
3,837Shares Held
1.25BCall Options Held
15.7MPut Options Held
11.3M-
Vanguard Group Inc Valley Forge, PA172MShares$29.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.4 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.84 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.57 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $300B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...